The US Food and Drug Administration (FDA) has granted full approval for Moderna’s COVID-19 vaccine, Spikevax, in children aged 6 months to 11 years who are at a higher risk of the disease. The vaccine was previously available under emergency use authorization for this group.
CDC Director Robert F. Kennedy Jr. has stated that routine COVID-19 vaccinations should not be recommended for healthy children and pregnant women. However, the Centers for Disease Control and Prevention (CDC) continues to recommend updated COVID vaccines for everyone aged 6 months and older, following expert guidance.
Moderna expects to make its updated vaccine available for eligible populations starting from the 2025-26 respiratory virus season. The company’s shares rose 2% after receiving FDA approval.
Source: https://www.ksl.com/article/51343839/moderna-gets-full-approval-for-covid-shot-in-at-risk-children-6-months-and-older